Wells Fargo & Company Gossamer Bio, Inc. Transaction History

Wells Fargo & Company

$507 Billion
Q3 2025

A detailed history of Wells Fargo & Company transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 116,667 shares of GOSS stock, worth $316,167. This represents 0.0% of its overall portfolio holdings.

Number of Shares

116,667

Previous 98,157 18.86%

Holding current value

$316,167

Previous $120,000 155.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$1.21 - $3.46 $22,397 - $64,044	18,510 Added 18.86%	116,667 $306,000
Q2 2025 Aug 14, 2025	BUY	$0.78 - $1.44 $73,125 - $135,001	93,751 Added 2127.8%	98,157 $120,000
Q1 2025 May 13, 2025	BUY	$0.85 - $1.53 $3,745 - $6,741	4,406 New	4,406 $4,000
Q3 2024 Nov 13, 2024	SELL	$0.79 - $1.25 $107 - $170	-136 Reduced 34.0%	264 $0
Q2 2024 Aug 13, 2024	SELL	$0.51 - $1.27 $800 - $1,992	-1,569 Reduced 79.69%	400 $0

Q1 2024 May 10, 2024	BUY	$0.8 - $1.51 $20 - $39	26 Added 1.34%	1,969 $2,000
Q4 2023 Feb 09, 2024	BUY	$0.48 - $1.08 $38 - $86	80 Added 4.29%	1,943 $1,000
Q3 2023 Nov 13, 2023	BUY	$0.78 - $1.82 $701 - $1,636	899 Added 93.26%	1,863 $1,000
Q2 2023 Aug 15, 2023	SELL	$0.98 - $1.53 $11,471 - $17,910	-11,706 Reduced 92.39%	964 $1,000
Q1 2023 May 12, 2023	BUY	$0.96 - $2.92 $12,163 - $36,996	12,670 New	12,670 $15,000
Q3 2022 Nov 14, 2022	SELL	$7.21 - $14.88 $3,215 - $6,636	-446 Reduced 11.8%	3,335 $39,000
Q2 2022 Aug 12, 2022	SELL	$5.97 - $9.97 $19,056 - $31,824	-3,192 Reduced 45.78%	3,781 $31,000
Q1 2022 May 16, 2022	SELL	$8.44 - $12.49 $179,274 - $265,300	-21,241 Reduced 75.29%	6,973 $60,000
Q4 2021 Feb 14, 2022	BUY	$10.12 - $14.07 $126,752 - $176,226	12,525 Added 79.83%	28,214 $319,000
Q3 2021 Nov 15, 2021	BUY	$7.25 - $13.23 $1,297 - $2,368	179 Added 1.15%	15,689 $198,000
Q2 2021 Aug 16, 2021	SELL	$8.0 - $9.75 $33,272 - $40,550	-4,159 Reduced 21.14%	15,510 $126,000
Q1 2021 May 13, 2021	SELL	$8.63 - $10.94 $330,606 - $419,100	-38,309 Reduced 66.08%	19,669 $182,000
Q4 2020 Feb 09, 2021	BUY	$8.3 - $13.59 $147,997 - $242,323	17,831 Added 44.41%	57,978 $560,000
Q3 2020 Nov 05, 2020	SELL	$11.3 - $14.75 $172,528 - $225,203	-15,268 Reduced 27.55%	40,147 $497,000
Q2 2020 Aug 13, 2020	BUY	$9.52 - $15.98 $123,931 - $208,027	13,018 Added 30.71%	55,415 $721,000
Q1 2020 May 14, 2020	BUY	$8.0 - $15.48 $339,176 - $656,305	42,397 New	42,397 $430,000

Others Institutions Holding GOSS

# of Institutions

181

Shares Held

163M

Call Options Held

8.11M

Put Options Held

211K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $255M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Gossamer Bio, Inc. Transaction History